Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on April 22, 2025
BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET
GlobeNewswire
·
April 22, 2025
PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its first quarter …
Palvella Therapeutics Granted Additional U.S. Patent for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
GlobeNewswire
·
April 22, 2025
Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038 QTORIN™ rapamycin has the potential to be the first approved therapy and standard of care for microcystic lymphatic malformations in the U.S. WAYNE, Pa., …
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
GlobeNewswire
·
April 22, 2025
CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO …
Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025
GlobeNewswire
·
April 22, 2025
ST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 first quarter on …
InStride’s Hybrid Clinical Cohorts Fill High-Need Roles in Healthcare
GlobeNewswire
·
April 22, 2025
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- InStride, a human capital management company providing strategic education benefits, today announced a hybrid education model that empowers healthcare organizations to fill critical roles by developing talent …
Axsome Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 22, 2025
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in four upcoming …
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025
GlobeNewswire
·
April 22, 2025
SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report first quarter 2025 financial results on Tuesday, May 6, 2025, after market close. The company will host a conference …
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
GlobeNewswire
·
April 22, 2025
Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses pacemaker-indicated patients with uncontrolled hypertension …
Rapport Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 22, 2025
BOSTON and SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
GlobeNewswire
·
April 22, 2025
- Initiation of Upcoming Phase 1a/1b Clinical Trial Expected in the Second Quarter of 2025 - WAYNE, Pa, April 22, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel …
Amesite Announces NurseMagic™ Meets HIPAA Requirements for Individuals Users, in Addition to Enterprises
GlobeNewswire
·
April 22, 2025
DETROIT, April 22, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced NurseMagic™ now meets HIPAA requirements for all users. …
AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025
GlobeNewswire
·
April 22, 2025
DUBLIN and BERWYN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customisable solutions to support the specialty pharmaceutical industry, proudly announces its participation in Advanced Therapies Integrates North 2025, …
R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDE® Drug Eluting Bioresorbable Scaffold
GlobeNewswire
·
April 22, 2025
MOUNTAIN VIEW, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce …
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
GlobeNewswire
·
April 22, 2025
New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina will enable additional production of Regeneron’s biologic medicines and support high-paying jobs in the region Regeneron’s ongoing and planned investments in …
PrimeBiome Reviews: “Gut–Skin Miracle” or Just Hype? Expert Insights
GlobeNewswire
·
April 22, 2025
St. Petersburg, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- With over 19,000 customer reviews and rising buzz across wellness communities, Prime Biome is being hailed as a “gut–skin miracle”—but does it actually live up to the hype? Touted as a dual-action …
Prime Biome Reviews 2025: Updated Comprehensive Guide to the Revolutionary Gut & Skin Health Supplement!
GlobeNewswire
·
April 22, 2025
St. Petersburg, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Explore how PrimeBiome is transforming gut and skin health in 2025. This detailed review covers everything—from ingredients and expert opinions to real customer experiences—to help you decide if …
Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025
GlobeNewswire
·
April 22, 2025
Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral Rinse Phase 2a Study Now Fully Enrolled Across All Three Dose Cohorts Advancing Toward Phase 2b IND Submission and Broader Regulatory Engagement …
Alpha Bites Gummies Reviews (WARNING) Is It Safe for Men’s Health? Understanding Its Natural Ingredients And Benefits!
GlobeNewswire
·
April 22, 2025
ORLANDO, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Any man looking for an easier and more effective way to increase their overall health and vitality must have come across several dietary supplements with different claims. Choosing the best from this big …
Nitric Boost Ultra Reviews (BREAKING) Why Nitric Boost Ultra Stands Out As The #1 Natural Formula for Men’s Health?
GlobeNewswire
·
April 22, 2025
OMAHA, Neb., April 22, 2025 (GLOBE NEWSWIRE) -- Introducing Nitric Boost Ultra, a nutritional supplement that has been taking over the male supplement industry with a 5-star global rating and magnificent remarks. Online Nitric Boost Ultra reviews signify …
Mitolyn Reviews: Ingredients, Benefits, Pros and Cons! Honest Analysis Inside!
GlobeNewswire
·
April 22, 2025
Albany, New York, April 22, 2025 (GLOBE NEWSWIRE) -- If you're struggling with stubborn weight, low energy, or slow metabolism, Mitolyn might be the breakthrough you've been waiting for. Touted as a cutting-edge mitochondrial support supplement, Mitolyn is …